PURE Bioscience (OTCMKTS:PURE – Get Free Report) shares crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $0.06 and traded as high as $0.0649. PURE Bioscience shares last traded at $0.0649, with a volume of 500 shares traded.
PURE Bioscience Trading Down 7.3%
The company has a market cap of $9.62 million, a price-to-earnings ratio of -2.47 and a beta of 0.22. The stock has a 50 day moving average price of $0.07 and a two-hundred day moving average price of $0.06.
PURE Bioscience (OTCMKTS:PURE – Get Free Report) last announced its quarterly earnings data on Monday, June 15th. The company reported ($0.01) EPS for the quarter. The company had revenue of $0.51 million during the quarter.
About PURE Bioscience
PURE Bioscience, Inc is a San Diego, California–based company that develops and markets patented antimicrobial solutions for diverse industries. At the core of its technology portfolio is Silver Dihydrogen Citrate (SDC), an EPA-registered broad-spectrum biocide designed to neutralize bacteria, viruses, and fungi on contact. The company targets applications in food processing, water treatment, personal care, and medical device sanitation.
PURE’s product suite includes concentrate formulations and ready-to-use solutions.
Featured Articles
- Five stocks we like better than PURE Bioscience
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
